[Thalidomide combined with interferon in 12 cases of relapsed or refractory mantle cell lymphoma]

Zhonghua Xue Ye Xue Za Zhi. 2014 Nov;35(11):1013-5. doi: 10.3760/cma.j.issn.0253-2727.2014.11.014.

[Article in Chinese]

Authors

Qianmeng Hao¹, Xudong Wei¹, Qingsong Yin¹, Ruihua Mi¹, Fangfang Yuan¹, Hao Ai¹, Ping Wang¹, Yufu Li¹, Li'na Zhang¹, Yongping Song¹

Affiliation

¹ Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou　450008, China.

PMID: 25417881
DOI: 10.3760/cma.j.issn.0253-2727.2014.11.014

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Interferons
Lymphoma, Mantle-Cell / drug therapy*
Recurrence
Thalidomide

Substances

Thalidomide
Interferons